Skip to Content

Quest PharmaTech Inc - Stock Quote QPTFF

Rating as of

Morningstar's Quest PharmaTech Inc Stock Analysis

Currency in USD
Is it the right time to buy or sell?
Find out with Morningstar Premium
Is it the right time to buy or sell?
Find out with Morningstar Premium

1-Star Price


5-Star Price


Economic Moat


About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Quest PharmaTech Inc's Company Profile

Business Description

Quest PharmaTech Inc is a Canadian based pharmaceutical company developing targeted cancer therapy with its lead product MAb AR9.6, under development for a novel target- truncated O-glycans on MUC16 discovered at University of Nebraska Medical Center. The company is also developing products utilizing proprietary transdermal delivery technologies with a focus on dermatology and wound healing applications.

8123 Roper Road NW
Edmonton, AB, T6E 6S4, Canada
T +1 780 448-1400
Sector Healthcare
Industry Biotechnology
Most Recent Earnings Oct 31, 2021
Fiscal Year End Jan 31, 2022
Stock Type